Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00096356 · ClinicalTrials.gov registry record · Phase 1
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Phase 1 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 236
- Enrollment target
NCT00096356 is a Phase 1 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 236 participants.
The verdict
NCT00096356, a Phase 1 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 236 participants
- Enrollment target
Study Summary
RATIONALE: Coenzyme Q10 is a vitamin that may be effective in relieving fatigue and depression in women who are undergoing chemotherapy for breast cancer. PURPOSE: This randomized clinical trial is studying how well coenzyme Q10 works in relieving treatment-related fatigue in women with breast cancer.
Interventions
- DIETARY_SUPPLEMENT CoQ10 & Vitamin E
- DIETARY_SUPPLEMENT Placebo & Vitamin E
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 236 participants |
| Start Date | 2004-08-27 |
| Est. Completion | 2009-08-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00096356
The ClinicalTrials.gov registry entry for NCT00096356 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 236 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CoQ10 & Vitamin E is the first listed.
NCT00096356 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00096356 about?
NCT00096356 is a clinical study titled "Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer". RATIONALE: Coenzyme Q10 is a vitamin that may be effective in relieving fatigue and depression in women who are undergoing chemotherapy for breast cancer. PURPOSE: This randomized clinical trial is studying how well coenzyme Q10 works in relieving treatment-related fatigue in women with breast canc...
What is the current status of trial NCT00096356?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 236 participants. The study started on 2004-08-27. Estimated completion is 2009-08-31.
What interventions are being tested in trial NCT00096356?
The interventions under investigation include: CoQ10 & Vitamin E (DIETARY_SUPPLEMENT), Placebo & Vitamin E (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00096356?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.